Shortage of eligible patients for COVID-19 clinical trials warning
Gilead’s suspension of COVID-19 trials in China because of a shortage of suitable participants should serve as bellwether for studies in other countries, says GlobalData
Published
Please sign in or register for FREE
Sign in to OnMedica
Or sign in via
Are you a GP or Specialist Doctor, practising in UK, looking for:
- easy-to-digest, relevant updates and educational content
- a safe-space to share and collaborate with peers?
OnMedica is for you, sign up FOR FREE now!
No comments yet.